Home
Market Capitalization of Marksans Pharma Ltd

Marksans Pharma Ltd
NSE: MARKSANS
Market Cap
Key Highlights
- The Market Cap of Marksans Pharma Ltd is ₹ 8795 crore as of 13 Mar 25 .
- The Latest Trading Price of Marksans Pharma Ltd is ₹ 194.1 as of 13 Mar 15:30 .
- The dividend payouts of Marksans Pharma Ltd changed from ₹ 0.05 to ₹ 0.6 over 6 quarters. This represents a CAGR of 424.15% .

Marksans Pharma Ltd
NSE: MARKSANS
Share Price
Market Price of Marksans Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
13 Mar 2025 | 194.1 |
12 Mar 2025 | 197.55 |
11 Mar 2025 | 201.2 |
10 Mar 2025 | 198.35 |
07 Mar 2025 | 207.25 |
06 Mar 2025 | 211.7 |
05 Mar 2025 | 199.1 |
04 Mar 2025 | 199.95 |
03 Mar 2025 | 201.7 |
28 Feb 2025 | 204.7 |
SWOT Analysis Of Marksans Pharma Ltd
BlinkX Score for Marksans Pharma Ltd
Asset Value vs Market Value of Marksans Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Marksans Pharma Ltd
Historical P/E Ratio of Marksans Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Marksans Pharma Ltd
Historical Revenue of Marksans Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Marksans Pharma Ltd
Historical EBITDA of Marksans Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Marksans Pharma Ltd
Historical Net Profit of Marksans Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Marksans Pharma Ltd
Historical Dividend Payouts of Marksans Pharma Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Marksans Pharma Ltd
About Marksans Pharma Ltd
- Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
- Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
- The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
- The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
- Marksans Pharma Limited (formerly M/s.
Marksans Pharma Ltd News Hub
Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz
Read more
21 Aug 24
Marksans Pharma gets EIR from USFDA for Goa facility
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
20 Aug 24
Marksans Pharma's Verna unit successfully completes USFDA inspection
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its
Read more
20 Aug 24
Marksans Pharma to convene AGM
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se
Read more
20 Aug 24